1
|
Laszlo R, Scharhag J, Burgstahler C, Striegel H, Steinacker JM. [Sports cardiology : Overview of relevant clinical topics]. Herz 2017; 43:53-60. [PMID: 28116464 DOI: 10.1007/s00059-016-4521-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/24/2016] [Accepted: 11/26/2016] [Indexed: 10/20/2022]
Abstract
Physical activity is nowadays an established therapeutic principle concerning primary and secondary prevention of cardiovascular diseases; therefore, in internal sports medicine various aspects go beyond basic cardiological knowledge and require special medical expertise (sports cardiology). Acute cardiac risk is increased during physical activity; therefore, physical activity should be individually phased under consideration of the whole clinical situation. Physical training results in a functional adaptation of the cardiovascular system. Moreover, a structural adaptation can also be observed in competitive athletes but a differentiation between athlete's heart and cardiomyopathy is sometimes challenging. Preparticipation screening verifiably reduces the incidence of sudden cardiac death in athletes. Respective recommendations for the required diagnostics have been published and statutory health insurances are increasingly more willing to bear the incurred costs. Statistically, doping is more frequent in performance-orientated leisure time sports than in competitive sports. Drugs which are relevant for doping have partially irreversible cardiac side effects.
Collapse
Affiliation(s)
- R Laszlo
- Sektion Sport- und Rehabilitationsmedizin, Universitätsklinikum Ulm, Leimgrubenweg 14, 89070, Ulm, Deutschland.
| | - J Scharhag
- Institut für Sport- und Bewegungsmedizin, Universität des Saarlandes, Saarbrücken, Deutschland
| | - C Burgstahler
- Abteilung für Sportmedizin, Medizinische Klinik V, Universitätsklinikum Tübingen, Tübingen, Deutschland
| | - H Striegel
- Abteilung für Sportmedizin, Medizinische Klinik V, Universitätsklinikum Tübingen, Tübingen, Deutschland
| | - J M Steinacker
- Sektion Sport- und Rehabilitationsmedizin, Universitätsklinikum Ulm, Leimgrubenweg 14, 89070, Ulm, Deutschland
| |
Collapse
|
2
|
Schwarz S, Boscheri A, Christle J, Duvinage A, Esefeld K, Fricke H, Pitsch N, Pressler A, Weichenberger M, Halle M. [Exercise training in the therapy of heart diseases: Current evidence and future options]. Herz 2016; 41:159-69; quiz 170-1. [PMID: 26914583 DOI: 10.1007/s00059-016-4403-y] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/14/2023]
Abstract
Exercise training has been firmly established as an additional therapeutic strategy in addition to pharmacological and interventional treatment in patients with cardiovascular disease. Benefits for quality of life as well as prognosis have been confirmed for cardiovascular risk factors, ischemic heart disease, after myocardial infarction, in heart failure with preserved as well as reduced ejection fraction, in atrial fibrillation and in patients after catheter-assisted aortic valve implantation (TAVI), with an implantable cardioverter defibrillator (ICD) or with left ventricular assist devices (VAD). Training programs have to be tailored according to the disease, stage of disease, comorbidities, age of the patient, medication as well as exercise capacity. For prescribing exercise mode and intensity, a maximum exercise test has to be performed. Ideally, this is accompanied by spirometry to assess maximum values such as maximum oxygen consumption. Training intensity will then be prescribed according to the optimal training range and maximum training intensity.
Collapse
Affiliation(s)
- S Schwarz
- Präventive und Rehabilitative Sportmedizin, Klinikum rechts der Isar, TU München, Georg-Brauchle-Ring 56, 80992, München, Deutschland
| | - A Boscheri
- Präventive und Rehabilitative Sportmedizin, Klinikum rechts der Isar, TU München, Georg-Brauchle-Ring 56, 80992, München, Deutschland
| | - J Christle
- Präventive und Rehabilitative Sportmedizin, Klinikum rechts der Isar, TU München, Georg-Brauchle-Ring 56, 80992, München, Deutschland
| | - A Duvinage
- Präventive und Rehabilitative Sportmedizin, Klinikum rechts der Isar, TU München, Georg-Brauchle-Ring 56, 80992, München, Deutschland
- Deutsches Zentrum für Herzkreislaufforschung (DZHK), Munich Heart Alliance, München, Deutschland
| | - K Esefeld
- Präventive und Rehabilitative Sportmedizin, Klinikum rechts der Isar, TU München, Georg-Brauchle-Ring 56, 80992, München, Deutschland
| | - H Fricke
- Präventive und Rehabilitative Sportmedizin, Klinikum rechts der Isar, TU München, Georg-Brauchle-Ring 56, 80992, München, Deutschland
| | - N Pitsch
- Präventive und Rehabilitative Sportmedizin, Klinikum rechts der Isar, TU München, Georg-Brauchle-Ring 56, 80992, München, Deutschland
| | - A Pressler
- Präventive und Rehabilitative Sportmedizin, Klinikum rechts der Isar, TU München, Georg-Brauchle-Ring 56, 80992, München, Deutschland
| | - M Weichenberger
- Präventive und Rehabilitative Sportmedizin, Klinikum rechts der Isar, TU München, Georg-Brauchle-Ring 56, 80992, München, Deutschland
| | - M Halle
- Präventive und Rehabilitative Sportmedizin, Klinikum rechts der Isar, TU München, Georg-Brauchle-Ring 56, 80992, München, Deutschland.
- Deutsches Zentrum für Herzkreislaufforschung (DZHK), Munich Heart Alliance, München, Deutschland.
- Else Kröner-Fresenius-Zentrum, Klinikum rechts der Isar, München, Deutschland.
| |
Collapse
|
3
|
Górski A, Weber-Dabrowska B. The potential role of endogenous bacteriophages in controlling invading pathogens. Cell Mol Life Sci 2005; 62:511-9. [PMID: 15747058 DOI: 10.1007/s00018-004-4403-6] [Citation(s) in RCA: 109] [Impact Index Per Article: 5.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
Abstract
Bacteriophages (phages) are omnipresent in our environment, and recent studies highlight their potential impact on the microbial world. Phages can also be present in mammalian organisms, including man (intestines, oral cavity, urine, sputum and serum). Data are available which suggest that those endogenous phages could play an important role in eliminating bacteria and regulating the body ecosystem. Furthermore, our most recent findings suggest that phages can exert immunosuppressive action in the gut, helping control local inflammatory and autoimmune reactions, and demonstrate anticancer activity. We hypothesize that phages could act in concert with the immune system in immunosurveillance against bacteria, viruses and cancer.
Collapse
Affiliation(s)
- Andrzej Górski
- L. Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, 53114, Wroclaw, Poland.
| | | |
Collapse
|